Dynamic Transitions in Steatotic Liver Disease Subtypes and Risk of Liver-Related Events: A Nationwide Cohort Study

Clinical and Molecular Hepatology · Published 2026-07-30 · DOI 10.3350/cmh.2026.0408

Free full text

Authors (5)

Yewan Park, Jooyi Jung, Seungbong Han, Hyeyeon Hong, Gi-Ae Kim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Park, Y., Jung, J., Han, S., et al. (2026). Dynamic Transitions in Steatotic Liver Disease Subtypes and Risk of Liver-Related Events: A Nationwide Cohort Study. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0408

Related articles

• Targeting ER lipid raft-associated 1 reveals a coordinated cholesterol-dependent vulnerability in hepatocellular carcinoma · Clinical and Molecular Hepatology · 2026 · Same journal
• Noncanonical EZH2 activity cooperates with FOXM1 to drive tumorigenesis and advanced progression in HCC · Clinical and Molecular Hepatology · 2026 · Same journal
• Viral load rather than transaminase: an international perspective on the KASL–EALA 2026 guideline for chronic hepatitis B · Clinical and Molecular Hepatology · 2026 · Same journal
• Genetic and Genomic Insights Across the SLD Spectrum · Clinical and Molecular Hepatology · 2026 · Same journal
• Oral anticoagulants and hepatic decompensation in patients with cirrhosis and atrial fibrillation: observational study · Clinical and Molecular Hepatology · 2026 · Same journal
• Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review · Clinical and Molecular Hepatology · 2026 · Same journal
• Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on “Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations” · Clinical and Molecular Hepatology · 2026 · Same journal
• Oncofetal reprogramming in hepatocellular carcinoma: linking developmental programs to cancer vaccines and immunotherapy · Clinical and Molecular Hepatology · 2026 · Same journal
• Interleukin-1β as target to induce synthetic lethality in KRAS mutant biliary tract cancer · Clinical and Molecular Hepatology · 2026 · Same journal
• Artificial Intelligence and Generative Models in Hepatology: From Large Language Models to Digital Pathology in Liver Disease Diagnosis and Treatment · Clinical and Molecular Hepatology · 2026 · Same journal